NET Power NPWR Q1 2026 Results Miss Estimates EPS 012 vs 007 Qualcomm Slides 11 as Semiconductor Sector Pulls Back From Record AIDriven Rally Endeavour EXK Delivers Q1 2026 Beat EPS 021 vs 013 Expected NYT Pips Puzzle Guide Hints and Walkthrough for May 18 Stocks Surge Amid Strong Earnings and Potential Iran Deal Key Events to Watch SpaceX Scrubs Starship V3 Test Flight Reschedules for Friday IPO Filing Reveals 15 Billion Program Cost Zoom Communications Reports Q1 Results Focus on AI Integration and Enterprise Growth Trump Seeks Supreme Court Intervention to Halt TikTok Ban Hong Kong Poised to Strengthen Gold Hub Status with New Clearing System Expected by July Jet Fuel Shortages Could Disrupt Summer Holiday Travel Plans ACI Q1 2026 Earnings EPS Beats Estimates by 1034 as Grocer Shows Resilience LMT Q1 2026 Earnings Earnings Miss Stock Rises Amid Defense Sector Optimism VVOS Q4 2025 Earnings EPS Misses Estimates as Loss Widens Stock Gains 431 Tonix Pharmaceuticals Q1 2026 Earnings WiderThanExpected Loss Compounds Investor Concerns RVMD Q1 2026 Earnings EPS Miss Reflects Increased RD Spending Pipeline Progress Continues PulteGroup PHM Q1 2026 Earnings Mixed Quarter as EPS Falls Slightly Short of Expectations Precigen Inc PGEN Holds Steady at 424 as Stock Nears Key Support Level Replimune Group REPL Rises 28 Approaching Resistance at 497 Scilex Holding SCLX Gains 771 Testing Resistance Near 725 Intelligent Bio Solutions INBS Surges 7 as Shares Rebound from Support Level Clarivate CLVT Holds Steady at 259 as Investors Weigh Support and Resistance Levels Newegg NEGG Reports Mixed Q4 2022 Revenue Beats but EPS Misses Soren SORNW Slips 1636 Testing 022 Support 20260515 Palvella Therapeutics Reports Positive Phase 2 Data for QTORIN Rapamycin in Cutaneous Venous Malformations Kwek Leng Peck Appointed ViceChairman of City Developments Limited New UK High Street Crime Unit to Target Gangs Using Shop Fronts for Money Laundering Jim Cramer Advises Investors to Focus on Upside Potential Not Past Stock Performance TME Q1 2026 Earnings EPS Beats Estimates Amid Market Headwinds Serina Therapeutics Inc SER Gains Nearly 5 as Stock Approaches Key Resistance